The onco-fusion protein BCR-ABL, which is produced in CML through the activation of SIRT1 mediated by STAT5, is essential for both the malignant transformation and the development of hematopoietic progenitor cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.